Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

September 01, 1983; Volume 226,Issue 3

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 908;
  • You have access
    Pharmacokinetics of chloroquine diphosphate in the dog.
    A F Aderounmu and L Fleckenstein
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 633-639;
  • You have access
    Reactivity and binding of beta-lactam antibiotics in rabbit renal cortex.
    M C Browning and B M Tune
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 640-644;
  • You have access
    Transport of methotrexate in cortical slices of monkey kidney: effect of organic anions and vincristine.
    T S Chen, B A Wenczak and K C Huang
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 645-649;
  • You have access
    Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia.
    J B Fischer, L A Waggaman, R W Ransom and A K Cho
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 650-655;
  • You have access
    Phencyclidine blood protein binding: influence of protein, pH and species.
    S M Owens, M Mayersohn and J R Woodworth
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 656-660;
  • You have access
    Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung.
    D A Wiersma and R A Roth
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 661-667;
  • You have access
    Alpha-1 adrenoceptors and calcium in isolated canine coronary arteries.
    T J Rimele, T W Rooke, L L Aarhus and P M Vanhoutte
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 668-672;
  • You have access
    Pre- and postnatal effects of caffeine on brain biogenic amines, cyclic nucleotides and behavior in developing rats.
    J T Concannon, J M Braughler and M D Schechter
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 673-679;
  • You have access
    Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    L X Cubeddu, I S Hoffmann, M K James and D M Niedzwiecki
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 680-685;
  • You have access
    Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    B K Koe, A Weissman, W M Welch and R G Browne
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 686-700;
  • You have access
    Verapamil inhibition of vasopressin-stimulated water flow: possible role of intracellular calcium.
    R M Burch and P V Halushka
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 701-705;
  • You have access
    Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
    P Sánchez-Blázquez, J Garzón and N M Lee
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 706-711;
  • You have access
    Evaluation of presynaptic histamine receptors in the canine renal vascular bed.
    N W Robie and L A Barker
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 712-719;
  • You have access
    Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors.
    G D Frye, T J McCown and G R Breese
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 720-725;
  • You have access
    Antihypertensive activity of dl-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl prostaglandin E2 methyl ester (CL 115,347), a new orally and transdermally long-acting antihypertensive agent.
    P S Chan, P Cervoni, M A Ronsberg, R C Accomando, G J Quirk, P A Scully and L M Lipchuck
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 726-732;
  • You have access
    Effect of chronic lithium treatment on rat pineal rhythms: N-acetyltransferase, N-acetylserotonin and melatonin.
    F D Yocca, V de Paul Lynch and E Friedman
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 733-737;
  • You have access
    Differential effects of prototype opioid agonists on the acquisition of conditional discriminations in monkeys.
    J M Moerschbaecher and D M Thompson
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 738-748;
  • You have access
    Stimulation of prostaglandin production in rabbit ileal mucosa by bradykinin.
    S A Hojvat, M W Musch and R J Miller
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 749-755;
  • You have access
    Effects of drugs on stimulus control of behavior. II. Degree of stimulus control as a determinant of effect.
    J L Katz
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 756-763;
  • You have access
    Noradrenergic modulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1-methylxanthine.
    J F Reinhard, M P Galloway and R H Roth
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 764-769;
  • You have access
    Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
    T J Cicero, D P Owens, P F Schmoeker and E R Meyer
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 770-775;
  • You have access
    Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788.
    N A Ator and R R Griffiths
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 776-782;
  • You have access
    Physical dependence on diazepam and lorazepam in the dog.
    L F McNicholas, W R Martin and S Cherian
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 783-789;
  • You have access
    Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid.
    H A Singer and M J Peach
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 790-795;
  • You have access
    Endothelium-dependent relaxation of rabbit aorta. II. Inhibition of relaxation stimulated by methacholine and A23187 with antagonists of arachidonic acid metabolism.
    H A Singer and M J Peach
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 796-801;
  • You have access
    Dopamine antagonist effect of verapamil on isolated perfused rabbit ear artery.
    C E Johnson, O S Steinsland and A Scriabine
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 802-805;
  • You have access
    Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.
    E G Mimnaugh, T E Gram and M A Trush
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 806-816;
  • You have access
    Effects of chronic nicotine infusion on tolerance development and nicotinic receptors.
    M J Marks, J B Burch and A C Collins
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 817-825;
  • You have access
    Mobilization of cellular choline by stimulation of muscarine receptors in isolated chicken heart and rat cortex in vivo.
    R Corradetti, R Lindmar and K Löffelholz
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 826-832;
  • You have access
    A study of the kinetics of chlorpromazine sulfoxide by a specific radioimmunoassay after a single oral dose of chlorpromazine in healthy volunteers.
    P K Yeung, J W Hubbard, J K Cooper and K K Midha
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 833-838;
  • You have access
    High anticonvulsant potency of gamma-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy.
    W Löscher, H H Frey, R Reiche and D Schultz
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 839-844;
  • You have access
    Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment.
    W Löscher and H Nau
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 845-854;
  • You have access
    Differential role of M-1 and M-2 receptors in sympathetic ganglia of the pithed normotensive rat in alpha adrenoceptor-mediated vasoconstriction.
    B Wilffert, D Davidesko, P B Timmermans and P A van Zwieten
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 855-860;
  • You have access
    Alpha adrenergic receptor subtypes in human, monkey and dog cerebral arteries.
    N Toda
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 861-868;
  • You have access
    Styrene oxide metabolism in rhesus monkey liver: enzyme activities in subcellular fractions and in isolated hepatocytes.
    G M Pacifici, B Lindberg, H Glaumann and A Rane
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 869-875;
  • You have access
    Effects of glial uptake and desensitization on the activity of gamma-aminobutyric acid (GABA) and its analogs at the cat dorsal root ganglion.
    J P Gallagher, J Nakamura and P Shinnick-Gallagher
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 876-884;
  • You have access
    Negative chronotropic and positive inotropic actions of phencyclidine on isolated atrial muscle in guinea pigs and rats.
    K Temma, T Akera, T M Brody and R H Rech
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 885-892;
  • You have access
    Medullary gamma-aminobutyric acid (GABA) receptors and the regulation of blood pressure in the rat.
    R N Willette, A J Krieger, P P Barcas and H N Sapru
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 893-899;
  • You have access
    Enhancement by locally generated angiotensin II of release of the adrenergic transmitter in the isolated rat kidney.
    T Böke and K U Malik
    Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 900-907;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 226, Issue 3
1 Sep 1983
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics